US Patent Issued to KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION on Oct. 6 for "Bacteriophage effective for controlling Salmonella typhimurium and its derived biofilm, and an antibacterial composition comprising the same" (South Korean Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,751,982, issued on Oct. 6, was assigned to KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (Daegu, South Korea).

"Bacteriophage effective for controlling Salmonella typhimurium and its derived biofilm, and an antibacterial composition comprising the same" was invented by Mi-Kyung Park (Daegu, South Korea), Su-Hyeon Kim (Daegu, South Korea) and Heejeong Lee (Busan, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are a bacteriophage KFS-ST3 having specific killing ability for Salmonella typhimurium and its derived biofilm, and a pharmaceutical composition for preventing or treating infectious diseases caused by Sa...